indexo.dev

exemptia.com

.com crawl

First seen 2026-05-09 · Last seen 2026-05-09 · ok HTTP/1.1 200 1360 ms crawled 2026-05-15

IN · 3.6.231.247 · AS16509 Amazon.com, Inc.

Reputation 87/100 weak security headers no dmarc policy

Classifying

HTML metadata

Title
Adalimumab India - Adalimumab Dosage - Adalimumab - Adalimumab Biosimilar - Biosimilar Of Adalimumab
Description
Adalimumab, trade name Exemptia, is a potent TNF-inhibitor and anti-inflammatory drug manufactured and promoted by Zydus Cadila in India. Adalimumab Biosimilar Dosage is prescribed to people who have Psoriatic and Rheumatoid Arthritis.
Language
en
Canonical
https://exemptia.com/

Open Graph

title
Adalimumab India - Adalimumab Dosage - Adalimumab - Adalimumab Biosimilar - Biosimilar Of Adalimumab
description
Adalimumab, trade name Exemptia, is a potent TNF-inhibitor and anti-inflammatory drug manufactured and promoted by Zydus Cadila in India. Adalimumab Biosimilar Dosage is prescribed to people who have Psoriatic and Rheumatoid Arthritis.

Technology

Server
Apache
Analytics
  • Google Tag Manager
Fonts
  • Google Fonts

Third-party hosts loaded (2)

  • www.googletagmanager.com×2
  • fonts.googleapis.com×1

Contact

Phone

Registration

Registrar
PDR Ltd. d/b/a PublicDomainRegistry.com
Created
2014-10-18
Expires
2028-10-18 882 days left
Updated
2024-07-11
Name servers
  • ns35.domaincontrol.com
  • ns36.domaincontrol.com

DNS records live

NS
  • ns35.domaincontrol.com
  • ns36.domaincontrol.com
MX
  • 0 mail.exemptia.com

Email authentication weak

SPF
not published
DMARC
not published
DKIM
no key found at common selectors

Certificate (current)

E8
from 2026-03-26 to 2026-06-24
Expires in 35 days

Full certificate history on crt.sh ↗

HTTP security headers

Header hygiene 30/100 Checked live page: https://exemptia.com/

findings
  • missing HSTS
  • missing Content Security Policy
  • missing frame protection
  • missing content type protection
  • missing Referrer Policy
  • missing Permissions Policy

Links to (5)

Linked from (1)